ATM mutant B-CLL tumors have a proven defect in the repair of ionizing radiation induced damage, a function normally mediated by the BRCA pathway. ATM phosphorylates BRCA1 after gamma radiation induced DNA damage. The gene discussed is BRCA1; the disease is B-cell chronic lymphocytic leukemia.